ARTICLE

Volume 10,Issue 7

All Issues
Submit to JCNR
Cite this article
1
Citations
2
Views
18 January 2024
Clinical Efficacy Analysis of Tiotropium Bromide Combined with Budesonide and Formoterol Inhalation in Treating COPD
Hailing Lin ,  Yanjie Lv
Show Less
1 Qingdao Shibei District People’s Hospital, Qingdao 266011, Shandong Province, China,
2 Qingdao Shibei District People’s Hospital, Qingdao 266011, Shandong Province, China,
JCNR 2024 , 8(1), 1–6; https://doi.org/10.26689/jcnr.v8i1.5870
© 2024 by the Authors. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Download PDF
Cite
XML
HTML
Abstract

Objective: To analyze the clinical efficacy of tiotropium bromide (TB) combined with budesonide formoterol (BUD/FM) inhalation in treating chronic obstructive pulmonary disease (COPD). Methods: 62 COPD patients admitted to the hospital between June 2020 and December 2022 were selected as samples for this study. The patients were divided into a combination group and a conventional group using the random number table method, with 31 cases in each group. The patients in the combination group were treated with TB combined with BUD/FM inhalation, whereas the patients in the conventional group were treated with BUD/FM inhalation only. The treatment efficacy and changes in lung function indicators of both groups were compared. Results: The total efficacy of treatment in the combined group was higher than that in the conventional group, and the difference was statistically significant (P < 0.05). Before treatment, there was no difference in pulmonary function indicators between the two groups (P > 0.05). After three months of treatment, all lung function indicators of the combined group were higher than those of the conventional group, and the difference was statistically significant (P < 0.05). Conclusion: Combining TB with BUD/FM inhalation therapy increases the efficacy of treatment for patients with COPD. Besides, it also improves lung function and leads to a better prognosis.

References
Shi H, Yun C, Wei H, et al., 2020, Clinical Observation of Tiotropium Bromide Combined with Budesonide and Formoterol in Treating Asthma-COPD Overlap Syndrome. Chinese Pharmacist, 23(5): 901-904.
Wu L, 2019, Clinical Study on Budesonide Formoterol Inhalation and Tiotropium Bromide Inhalation in Treating Elderly Chronic Obstructive Pulmonary Disease. Chinese Medicine and Clinic, 19(18): 3146-3148.
Li Z, 2019, Comparative Study on the Efficacy, Safety, and Quality of Life of Budesonide, Formoterol, Salmeterol, and Fluticasone Inhalation in Remission Treating Chronic Obstructive Pulmonary Disease. Guizhou Medicine, 43(4): 553-555.
Li J, Mi J, 2023, Clinical Study of Budesonide Formoterol Powder Inhalation Combined with Compound Ipratropium Bromide Solution Atomization for Chronic Obstructive Pulmonary Disease Complicated by Pulmonary Arterial Hypertension. Guizhou Medicine, 47(2): 228-230.
Xu L, Zhu J, Bian H, et al., 2020, The Efficacy of Budesonide Formoterol Combined with Tiotropium Bromide Inhalation in Treating COPD and its Impact on CRP, SaO2, and PH Levels. Modern Biomedicine Progress, 20(22): 4369-4372.
Ren Yan, 2018, Evaluation of the Clinical Efficacy of Inhaled Corticosteroids Combined with Tiotropium Bromide in the Treatment of Asthma-COPD Overlap Syndrome. Psychologists, 24(19):166-167.
Xu J, 2023, Effects of Budesonide Formoterol Combined with Tiotropium Bromide Powder Inhalation on Micro-Inflammatory and Blood Gas Indicators in Chronic Obstructive Pulmonary Disease. Shanxi Medical Journal, 52(3): 210–213.
Wang X, Luan N, Jin D, 2019, The Efficacy of Tiotropium Bromide Combined with Budesonide and Formoterol in Treating Stable COPD and its Impact on Cellular Immune Function. Chinese Physician Journal, 21(8): 1254-1256.
Wang N, Li N, Han Q, et al., 2021, Clinical Study of Budesonide Formoterol Combined with Tiotropium Bromide in Treating Asthma-Chronic Obstructive Pulmonary Disease Overlap. Chinese Comprehensive Clinical Journal, 37(1): 39-45.
Li Y, Yin J, Yang W, et al., 2020, Effects of Budesonide and Formoterol Inhalation Therapy on Pulmonary Function and Airway Resistance in Patients with Acute and Stable COPD. Guangdong Medicine, 41(22): 2307-2311.
Li F, Zhang G, 2021, The Effectiveness of Tiotropium Bromide and Xinbico Duoba in Treating Chronic Obstructive Pulmonary Disease and its Impact on Patients’ Exercise Tolerance. Guizhou Medicine, 45(9): 1396–1397.
Huang Y, Cao X, 2020, Observation on the Effect of Budesonide and Formoterol Powder Inhalation in Treating Patients with Chronic Obstructive Pulmonary Disease. Hebei Medicine, 42(19): 2968-2970.
Cheng H, Che H, Wang L, 2019, Clinical Study of Bufei Huoxue Capsule Combined with Budesonide and Formoterol Powder Inhalation in Treating Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Modern Medicine and Clinic, 34(12): 3589-3593.
Liang Q, Ma H, He L, et al., 2020, Observation on the Therapeutic Effect of Tiotropium Bromide Combined with Budesonide and Formoterol in Patients with Stable Chronic Obstructive Pulmonary Disease. Chinese Medicine and Clinic, 20(16): 2736-2737.
Yao L, Han L, Li N, 2019, Effects of Budesonide/Formoterol Powder Inhalation Combined with Montelukast Sodium on FeNO and Lung Function in Patients with Chronic Persistent Bronchial Asthma. Guangdong Medicine, 40(13): 1944-1947.
Share
Back to top
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept